PreveCeutical Medical (FRA:18H0) Days Payable: 0.00 (As of Dec. 2025)


What is PreveCeutical Medical Days Payable?

PreveCeutical Medical FRA:18H0 Days Payable is 0.00 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 700 Biotechnology companies, PreveCeutical Medical ranks worse than 142857% on this metric.

PreveCeutical Medical's average Accounts Payable for the three months ended in Dec. 2025 was €0.00 Mil. PreveCeutical Medical's Cost of Goods Sold for the three months ended in Dec. 2025 was €0.00 Mil.

The historical rank and industry rank for PreveCeutical Medical's Days Payable or its related term are showing as below:

During the past 11 years, PreveCeutical Medical's highest Days Payable was 169360.00. The lowest was 9033.75. And the median was 31070.63.

FRA:18H0's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.83
* Ranked among companies with meaningful Days Payable only.

PreveCeutical Medical's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00). stayed the same


PreveCeutical Medical Days Payable Historical Data

* Premium members only.

The historical data trend for PreveCeutical Medical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical Days Payable Chart

PreveCeutical Medical Annual Data
Trend Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PreveCeutical Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:18H0 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, PreveCeutical Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's Days Payable distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's Days Payable falls into.



PreveCeutical Medical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

PreveCeutical Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

PreveCeutical Medical's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
PreveCeutical Medical (FRA:18H0) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PreveCeutical Medical and its competitors. Over the past decade, PreveCeutical Medical's Days Payable has ranged from 9,033.75 to 169,360.00. According to the industry distribution chart, PreveCeutical Medical ranks #999999 out of 700 companies in the Biotechnology industry.
Is PreveCeutical Medical's Days Payable too high?
PreveCeutical Medical's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 9,033.75 to a high of 169,360.00. Based on the distribution chart, PreveCeutical Medical ranks #999999 out of 700 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does PreveCeutical Medical's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PreveCeutical Medical ranks #999999 out of 700 companies for Days Payable. This places PreveCeutical Medical in the lower half of its industry. The industry median Days Payable is 112.83. Historically, PreveCeutical Medical's own Days Payable has ranged from 9,033.75 to 169,360.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.83, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PreveCeutical Medical and its competitors. For the Biotechnology industry, the median Days Payable is 112.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PreveCeutical Medical's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (FRA:18H0) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PreveCeutical Medical (FRA:18H0), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PreveCeutical Medical Business Description

Other Exchanges PRVCF:USAPREV:Canada
Address 550 Burrard Street, Bentall 5, Suite 2501, Vancouver, BC, CAN, V6C 2B5
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.